297 filings
Page 9 of 15
SC 13G/A
Flynn James E
8 Nov 19
Xeris Pharmaceuticals Inc
4:59pm
10-Q
2019 Q3
XERS
Xeris Pharmaceuticals Inc
Quarterly report
7 Nov 19
4:36pm
8-K
XERS
Xeris Pharmaceuticals Inc
7 Nov 19
Xeris Pharmaceuticals Reports Third Quarter 2019 Financial Results and Highlights
8:22am
4
XERS
Xeris Pharmaceuticals Inc
16 Oct 19
XERIS PHARMACEUTICALS / STEVEN PRESTRELSKI ownership change
4:27pm
4
XERS
Xeris Pharmaceuticals Inc
2 Oct 19
XERIS PHARMACEUTICALS / Mark Thierer ownership change
5:12pm
3
XERS
Xeris Pharmaceuticals Inc
2 Oct 19
XERIS PHARMACEUTICALS / Mark Thierer ownership change
5:08pm
8-K
XERS
Xeris Pharmaceuticals Inc
1 Oct 19
Xeris Pharmaceuticals Appoints Mark Thierer to Board of Directors
4:03pm
4/A
Beth Hecht
12 Sep 19
XERIS PHARMACEUTICALS / Beth Hecht ownership change
5:35pm
8-K
XERS
Xeris Pharmaceuticals Inc
10 Sep 19
XERIS PHARMACEUTICALS RECEIVES U.S. FDA APPROVAL FOR GVOKE™ (glucagon), THE FIRST READY-TO-USE STABLE LIQUID GLUCAGON FOR SEVERE HYPOGLYCEMIA
5:26pm
EFFECT
XERS
Xeris Pharmaceuticals Inc
22 Aug 19
Notice of effectiveness
12:15am
CORRESP
XERS
Xeris Pharmaceuticals Inc
19 Aug 19
Correspondence with SEC
12:00am
UPLOAD
XERS
Xeris Pharmaceuticals Inc
8 Aug 19
Letter from SEC
12:00am
S-3
XERS
Xeris Pharmaceuticals Inc
6 Aug 19
Shelf registration
5:29pm
10-Q
2019 Q2
XERS
Xeris Pharmaceuticals Inc
Quarterly report
6 Aug 19
4:13pm
8-K
XERS
Xeris Pharmaceuticals Inc
6 Aug 19
Xeris Pharmaceuticals Announces Second Quarter 2019 Financial Results and Highlights
4:09pm
4
Beth Hecht
3 Jul 19
XERIS PHARMACEUTICALS / Beth Hecht ownership change
4:58pm
4
XERS
Xeris Pharmaceuticals Inc
3 Jul 19
XERIS PHARMACEUTICALS / KENNETH ERLAND JOHNSON ownership change
4:57pm
4
XERS
Xeris Pharmaceuticals Inc
3 Jul 19
XERIS PHARMACEUTICALS / Barry M. Deutsch ownership change
4:57pm
4
XERS
Xeris Pharmaceuticals Inc
3 Jul 19
XERIS PHARMACEUTICALS / John Patrick Shannon Jr ownership change
4:56pm
8-K
XERS
Xeris Pharmaceuticals Inc
6 Jun 19
Other Events
4:09pm